BIOMAT Database Logo BIOMAT Database Logo

Comparison of matched-sibling donor BMT and unrelated donor BMT in children and adolescent with acquired severe aplastic anemia. 2010

H Yagasaki, and Y Takahashi, and A Hama, and K Kudo, and N Nishio, and H Muramatsu, and M Tanaka, and N Yoshida, and K Matsumoto, and N Watanabe, and K Kato, and K Horibe, and S Kojima
Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.

From January 1991 to March 2007, 61 children and adolescent with acquired severe aplastic anemia received BMT in our institutions. We retrospectively compared the outcome of 30 cases of matched-sibling donor BMT (MSD-BMT) and 31 cases of unrelated donor BMT (URD-BMT). We observed one graft failure among MSD-BMT recipients and three graft failures among URD-BMT recipients, respectively. No patients in the MSD-BMT group developed grades II-IV acute GVHD compared with 11 of 30 patients (37%) in the URD-BMT group (P<0.001). One of 30 MSD-BMT recipients (3%) developed chronic GVHD compared with 8 of 30 URD-BMT recipients (27%) (P=0.013). The incidence of EBV and CMV reactivation was 11 of 20 URD-BMT recipients and 23 of 30, respectively. One patient in the URD-BMT group died of a motor accident 5.5 years after BMT. Ten-year OS was 100% in MSD-BMT recipients and 93.8% (95% CI, 81.9-100%) in URD-BMT recipients, respectively (P=0.252). Ten-year failure-free survival was 96.7% (95% CI, 90.2-100%) in the MSD-BMT group and 84.7% (95% CI, 70.2-99.2%) in the URD-BMT group, respectively (P=0.161).

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D005260 Female Females
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases

Related Publications

H Yagasaki, and Y Takahashi, and A Hama, and K Kudo, and N Nishio, and H Muramatsu, and M Tanaka, and N Yoshida, and K Matsumoto, and N Watanabe, and K Kato, and K Horibe, and S Kojima
Comparison of HLA-matched sibling and unrelated donor transplantation in adult patients with acquired severe aplastic anemia.
August 2020, Bone marrow transplantation,
H Yagasaki, and Y Takahashi, and A Hama, and K Kudo, and N Nishio, and H Muramatsu, and M Tanaka, and N Yoshida, and K Matsumoto, and N Watanabe, and K Kato, and K Horibe, and S Kojima
[A comparative study of unrelated donor and matched-sibling donor allogeneic hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia].
December 2016, Zhonghua nei ke za zhi,
H Yagasaki, and Y Takahashi, and A Hama, and K Kudo, and N Nishio, and H Muramatsu, and M Tanaka, and N Yoshida, and K Matsumoto, and N Watanabe, and K Kato, and K Horibe, and S Kojima
Unrelated donor marrow transplants for severe acquired aplastic anemia.
January 1992, Bone marrow transplantation,
H Yagasaki, and Y Takahashi, and A Hama, and K Kudo, and N Nishio, and H Muramatsu, and M Tanaka, and N Yoshida, and K Matsumoto, and N Watanabe, and K Kato, and K Horibe, and S Kojima
Withdrawn: Matched sibling donor hematopoietic stem cell transplant in patients with acquired aplastic anemia.
December 2014, Current drug targets,
H Yagasaki, and Y Takahashi, and A Hama, and K Kudo, and N Nishio, and H Muramatsu, and M Tanaka, and N Yoshida, and K Matsumoto, and N Watanabe, and K Kato, and K Horibe, and S Kojima
Upfront Matched Unrelated Donor Transplantation in Aplastic Anemia.
August 2018, Hematology/oncology clinics of North America,
H Yagasaki, and Y Takahashi, and A Hama, and K Kudo, and N Nishio, and H Muramatsu, and M Tanaka, and N Yoshida, and K Matsumoto, and N Watanabe, and K Kato, and K Horibe, and S Kojima
Outcomes of matched sibling and alternative donor stem cell transplantation for 26 children with severe aplastic anemia.
January 2010, International journal of hematology,
H Yagasaki, and Y Takahashi, and A Hama, and K Kudo, and N Nishio, and H Muramatsu, and M Tanaka, and N Yoshida, and K Matsumoto, and N Watanabe, and K Kato, and K Horibe, and S Kojima
Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia.
June 2023, Blood,
H Yagasaki, and Y Takahashi, and A Hama, and K Kudo, and N Nishio, and H Muramatsu, and M Tanaka, and N Yoshida, and K Matsumoto, and N Watanabe, and K Kato, and K Horibe, and S Kojima
What is the most effective treatment of children with severe aplastic anemia who lack a matched sibling donor?
December 1996, Bone marrow transplantation,
H Yagasaki, and Y Takahashi, and A Hama, and K Kudo, and N Nishio, and H Muramatsu, and M Tanaka, and N Yoshida, and K Matsumoto, and N Watanabe, and K Kato, and K Horibe, and S Kojima
Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia.
April 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
H Yagasaki, and Y Takahashi, and A Hama, and K Kudo, and N Nishio, and H Muramatsu, and M Tanaka, and N Yoshida, and K Matsumoto, and N Watanabe, and K Kato, and K Horibe, and S Kojima
Risk factors affecting outcome of second HLA-matched sibling donor transplantations for graft failure in severe acquired aplastic anemia.
May 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
Copied contents to your clipboard!